BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33446833)

  • 1. Whole-exome sequencing identifies susceptibility genes and pathways for idiopathic pulmonary fibrosis in the Chinese population.
    Fang C; Huang H; Feng Y; Zhang Q; Wang N; Jing X; Guo J; Ferianc M; Xu Z
    Sci Rep; 2021 Jan; 11(1):1443. PubMed ID: 33446833
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of protein-altering variants in telomerase genes and their association with MUC5B common variant status in patients with idiopathic pulmonary fibrosis: a candidate gene sequencing study.
    Dressen A; Abbas AR; Cabanski C; Reeder J; Ramalingam TR; Neighbors M; Bhangale TR; Brauer MJ; Hunkapiller J; Reeder J; Mukhyala K; Cuenco K; Tom J; Cowgill A; Vogel J; Forrest WF; Collard HR; Wolters PJ; Kropski JA; Lancaster LH; Blackwell TS; Arron JR; Yaspan BL
    Lancet Respir Med; 2018 Aug; 6(8):603-614. PubMed ID: 29891356
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic role of MUC5B rs35705950 genotype in patients with idiopathic pulmonary fibrosis (IPF) on antifibrotic treatment.
    Biondini D; Cocconcelli E; Bernardinello N; Lorenzoni G; Rigobello C; Lococo S; Castelli G; Baraldo S; Cosio MG; Gregori D; Saetta M; Balestro E; Spagnolo P
    Respir Res; 2021 Apr; 22(1):98. PubMed ID: 33794872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Association between MUC5B polymorphism and susceptibility and severity of idiopathic pulmonary fibrosis.
    Jiang H; Hu Y; Shang L; Li Y; Yang L; Chen Y
    Int J Clin Exp Pathol; 2015; 8(11):14953-8. PubMed ID: 26823827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association Between the MUC5B Promoter Polymorphism rs35705950 and Idiopathic Pulmonary Fibrosis: A Meta-analysis and Trial Sequential Analysis in Caucasian and Asian Populations.
    Zhu QQ; Zhang XL; Zhang SM; Tang SW; Min HY; Yi L; Xu B; Song Y
    Medicine (Baltimore); 2015 Oct; 94(43):e1901. PubMed ID: 26512610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The minor T allele of the MUC5B promoter rs35705950 associated with susceptibility to idiopathic pulmonary fibrosis: a meta-analysis.
    Wu X; Li W; Luo Z; Chen Y
    Sci Rep; 2021 Dec; 11(1):24007. PubMed ID: 34907291
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MUC5B rs35705950 minor allele associates with older age and better survival in idiopathic pulmonary fibrosis.
    van der Vis JJ; Prasse A; Renzoni EA; Stock CJW; Caliskan C; Maher TM; Bonella F; Borie R; Crestani B; Petrek M; Wuyts WA; Wind AE; Molyneaux PL; Grutters JC; van Moorsel CHM
    Respirology; 2023 May; 28(5):455-464. PubMed ID: 36571111
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Shared genetic etiology between idiopathic pulmonary fibrosis and COVID-19 severity.
    Fadista J; Kraven LM; Karjalainen J; Andrews SJ; Geller F; ; Baillie JK; Wain LV; Jenkins RG; Feenstra B
    EBioMedicine; 2021 Mar; 65():103277. PubMed ID: 33714028
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A meta-analysis examining the association between the MUC5B rs35705950 T/G polymorphism and susceptibility to idiopathic pulmonary fibrosis.
    Lee MG; Lee YH
    Inflamm Res; 2015 Jun; 64(6):463-70. PubMed ID: 25926289
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic variants associated with idiopathic pulmonary fibrosis susceptibility and mortality: a genome-wide association study.
    Noth I; Zhang Y; Ma SF; Flores C; Barber M; Huang Y; Broderick SM; Wade MS; Hysi P; Scuirba J; Richards TJ; Juan-Guardela BM; Vij R; Han MK; Martinez FJ; Kossen K; Seiwert SD; Christie JD; Nicolae D; Kaminski N; Garcia JGN
    Lancet Respir Med; 2013 Jun; 1(4):309-317. PubMed ID: 24429156
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Potential clinical utility of MUC5B und TOLLIP single nucleotide polymorphisms (SNPs) in the management of patients with IPF.
    Bonella F; Campo I; Zorzetto M; Boerner E; Ohshimo S; Theegarten D; Taube C; Costabel U
    Orphanet J Rare Dis; 2021 Feb; 16(1):111. PubMed ID: 33639995
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The MUC5B promoter polymorphism is associated with idiopathic pulmonary fibrosis in a Mexican cohort but is rare among Asian ancestries.
    Peljto AL; Selman M; Kim DS; Murphy E; Tucker L; Pardo A; Lee JS; Ji W; Schwarz MI; Yang IV; Schwartz DA; Fingerlin TE
    Chest; 2015 Feb; 147(2):460-464. PubMed ID: 25275363
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucin 5B promoter polymorphism is associated with idiopathic pulmonary fibrosis but not with development of lung fibrosis in systemic sclerosis or sarcoidosis.
    Stock CJ; Sato H; Fonseca C; Banya WA; Molyneaux PL; Adamali H; Russell AM; Denton CP; Abraham DJ; Hansell DM; Nicholson AG; Maher TM; Wells AU; Lindahl GE; Renzoni EA
    Thorax; 2013 May; 68(5):436-41. PubMed ID: 23321605
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mapping the genetic architecture of idiopathic pulmonary fibrosis: Meta-analysis and epidemiological evidence of case-control studies.
    Singh P; Guin D; Pattnaik B; Kukreti R
    Gene; 2024 Feb; 895():147993. PubMed ID: 37977320
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of Muc5b promoter polymorphism on disease predisposition and survival in idiopathic interstitial pneumonias.
    van der Vis JJ; Snetselaar R; Kazemier KM; ten Klooster L; Grutters JC; van Moorsel CH
    Respirology; 2016 May; 21(4):712-7. PubMed ID: 26699835
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MUC5B promoter polymorphism in Japanese patients with idiopathic pulmonary fibrosis.
    Horimasu Y; Ohshimo S; Bonella F; Tanaka S; Ishikawa N; Hattori N; Kohno N; Guzman J; Costabel U
    Respirology; 2015 Apr; 20(3):439-44. PubMed ID: 25581455
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Polygenic Risk Score for Idiopathic Pulmonary Fibrosis and Interstitial Lung Abnormalities.
    Moll M; Peljto AL; Kim JS; Xu H; Debban CL; Chen X; Menon A; Putman RK; Ghosh AJ; Saferali A; Nishino M; Hatabu H; Hobbs BD; Hecker J; McDermott G; Sparks JA; Wain LV; Allen RJ; Tobin MD; Raby BA; Chun S; Silverman EK; Zamora AC; Ortega VE; Garcia CK; Barr RG; Bleecker ER; Meyers DA; Kaner RJ; Rich SS; Manichaikul A; Rotter JI; Dupuis J; O'Connor GT; Fingerlin TE; Hunninghake GM; Schwartz DA; Cho MH
    Am J Respir Crit Care Med; 2023 Oct; 208(7):791-801. PubMed ID: 37523715
    [No Abstract]   [Full Text] [Related]  

  • 18. The relationship between MUC5B promoter, TERT polymorphisms and telomere lengths with radiographic extent and survival in a Chinese IPF cohort.
    Wang H; Zhuang Y; Peng H; Cao M; Li Y; Xu Q; Xin X; Zhou K; Liang G; Cai H; Dai J
    Sci Rep; 2019 Oct; 9(1):15307. PubMed ID: 31653936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic variants associated with susceptibility to idiopathic pulmonary fibrosis in people of European ancestry: a genome-wide association study.
    Allen RJ; Porte J; Braybrooke R; Flores C; Fingerlin TE; Oldham JM; Guillen-Guio B; Ma SF; Okamoto T; John AE; Obeidat M; Yang IV; Henry A; Hubbard RB; Navaratnam V; Saini G; Thompson N; Booth HL; Hart SP; Hill MR; Hirani N; Maher TM; McAnulty RJ; Millar AB; Molyneaux PL; Parfrey H; Rassl DM; Whyte MKB; Fahy WA; Marshall RP; Oballa E; Bossé Y; Nickle DC; Sin DD; Timens W; Shrine N; Sayers I; Hall IP; Noth I; Schwartz DA; Tobin MD; Wain LV; Jenkins RG
    Lancet Respir Med; 2017 Nov; 5(11):869-880. PubMed ID: 29066090
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MUC5B promoter polymorphism and telomere length in patients with chronic hypersensitivity pneumonitis: an observational cohort-control study.
    Ley B; Newton CA; Arnould I; Elicker BM; Henry TS; Vittinghoff E; Golden JA; Jones KD; Batra K; Torrealba J; Garcia CK; Wolters PJ
    Lancet Respir Med; 2017 Aug; 5(8):639-647. PubMed ID: 28648751
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.